The new healthcare reform law modifies both Medicare Advantage (MA) and the Medicare prescription drug plan (PDP). Of particular importance are provisions that reduce payments to Medicare Advantage organizations over the next seven years.

This paper summarizes this and other key changes and offers perspective for organizations looking to understand how reform will affect their MA and PDP programs.